Could a CF drug help people with a different lung disease?
NCT ID NCT05743946
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether Trikafta, a drug already approved for cystic fibrosis, can help people with non-cystic fibrosis bronchiectasis (NCFBE). Thirty-two adults took the medication for 28 days. Researchers measured lung function, quality of life, and weight, and also looked at how cells respond to the drug in the lab.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Trikafta (elexacaftor, tezacaftor, ivacaftor)
What this could lead to
If it works, this could point toward a new treatment option for people with non-cystic fibrosis bronchiectasis who have certain CFTR mutations.
What could go wrong
This is a small, early-phase trial with only 32 participants, so results may not apply to everyone. The drug is already approved for cystic fibrosis, but its benefits for this different condition are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Emory Clinic
Atlanta, Georgia, 30322, United States